Press release: China’s trade surplus has passed $1 trillion – but could its next growth story be healthier, longer lives?
12 Nov, 2026
- Preventable conditions cost China US$198.8 billion a year in lost productivity among workers aged 50 to 64
- People aged 50 and over account for about US$1 in every US$3 of consumption in China – more than half by 2050
- New ILC report, supported by Pfizer, finds that closing China’s adult vaccination gap alone could be worth around US$170 billion a year – about 0.9% of GDP
- A companion report for the British Embassy Beijing notes the UK's existing services surplus with China of nearly £10 billion, with health, care and pensions expertise offering scope for deeper UK–China trade partnerships
- An early look at ILC’s new global Healthy Ageing and Prevention Index shows China rising five places since 2019
As China reports a trade surplus of US$1.04 trillion for the first ten months of 2026,[12] a new report from the International Longevity Centre UK (ILC) argues that China’s next source of growth could lie in keeping more of us healthy, working and spending as we age.
The report, The next frontier: Healthy ageing, prevention and economic growth in China, is supported by Pfizer and launched today, on World Pneumonia Day.
China values its silver economy at 7 trillion yuan today, and projects it will reach 30 trillion yuan – around £3.2 trillion, or roughly 10% of GDP – by 2035.[4, 9]
But ILC highlights that this longevity dividend relies on good health.
Longer lives, but not yet healthier ones
The report draws on the new forthcoming wave of ILC’s Healthy Ageing and Prevention Index, which shows China rising from 59th to 54th of 147 countries since 2019.[2] Among G20 countries, only India climbs further.
Life expectancy in China rose from 70.3 years in 2000 to 80.1 years in 2023. But the gap between life expectancy and healthy life expectancy widened from 8.4 to 10.6 years.[1, 11]
China spends less than US$100 per person a year on prevention – around 9% of its total health spending.[1, 6] Only around 15% of people aged 60 and over are vaccinated against flu, and around one in twenty against pneumococcal disease.[1, 5]
The cost is already showing up in the economy. ILC analysis finds that preventable conditions cost China US$198.8 billion a year in lost productivity among workers aged 50 to 64.[1]
China began raising its statutory retirement age in January 2025. But later retirement achieves little if preventable ill health pushes people out of work first.[1]
Making prevention pay
ILC analysis finds that vaccinating an older person against flu every year is worth around US$9,600 to society over the rest of their life, and pneumococcal vaccination around US$2,900 – many times the cost of the vaccines. Across everyone reached, that adds up to around US$2.4 trillion over their lifetimes, or around US$170 billion a year.[1, 5]
ILC sets out five ways for China to close the prevention gap:
- Organise prevention around the life course, with a defined preventive offer for every working-age adult
- Treat workforce health as productive capacity, helping older workers to stay in work
- Build health into housing, transport and environmental decisions
- Use purchasing power to bring flu, pneumococcal and shingles vaccines for older adults into the national immunisation programme
- Direct the silver economy towards maintaining independence, including a prevention tier in the new national long-term care insurance scheme[1, 8]
Tanya Singh, Senior Research Fellow, ILC, said
“In little more than two decades, life expectancy in China has risen by almost ten years. Our new Index shows it is climbing the global rankings for healthy ageing too. But the next gains won’t come from hospitals. They’ll come from prevention.
“China has already shown the world how to make a vaccine affordable at scale. Doing the same for the vaccines that protect us as we age would keep more people healthy, independent and in work – and return many times what it costs.”
A partnership opportunity for the UK
A companion ILC report, Making longevity work: equipping the UK to engage with China’s ageing economy, was commissioned by the British Embassy Beijing.[4]
It is published today. It notes that the UK already runs a services surplus with China of nearly £10 billion,[10] and argues that the UK’s experience in health technology assessment, care quality regulation, pensions and care workforce training complements China’s scale and speed.
UK businesses see the opportunity: nearly 70% are optimistic about their prospects in China over the next five to ten years.[4, 15] But appetite is not enough. The report calls on both governments to treat ageing as a cross-cutting economic priority, and to move from one-off engagements to sustained, properly evaluated joint pilots – regional as well as national.
It recommends that UK businesses adopt an “export-plus” approach – bundling products with training, maintenance and quality assurance – work through partnerships with individual provinces and cities, and invest in shared standards and evaluation.
David Sinclair, Chief Executive, ILC
“In 2017, a 79-year-old Arsenal supporter from Beijing, Liu Hongwen – ‘Granny Liu’ – won a VisitBritain competition to find China’s biggest Premier League fan, and flew to London to watch her team at the Emirates.[14] She is far from alone in spending on what she loves.
“China’s trade surplus shows what it can make for the world. Its ageing population shows what it could build at home.
“But the 30 trillion yuan opportunity will not grasp itself. Prevention is how we make sure more of us are healthy enough to share in it.
“Longevity is one of the key areas where collaboration clearly serves both countries. The UK can share its experience of building institutions and services. It should expect to learn from China’s speed and scale in return.”
Notes to editors
- About ILC. ILC is the UK’s leading authority on the impact of longevity on society. We combine evidence, solutions and networks to make change happen. ILC was established in 1997 as one of the founder members of an international network on longevity.
- The report. The next frontier: Healthy ageing, prevention and economic growth in China was produced by ILC and was made possible by a charitable grant from Pfizer. ILC-The-next-frontier-Healthy-ageing-prevention-and-economic-growth-in-China-1.pdf
- The British Embassy report. Making longevity work: equipping the UK to engage with China’s ageing economy was commissioned by the British Embassy Beijing through the Foreign, Commonwealth and Development Office. ILC produced it between September 2025 and February 2026, drawing on desk research, an expert roundtable and in-depth interviews. ILC-Making-Longevity-work-China-1.pdf
- The new Healthy Ageing and Prevention Index ranks 147 countries on six measures: life span, health span, secure employment, income, clean air and happiness. Life span and health span are drawn from the Global Burden of Disease Study 2023. The full Index will be launched on Thursday 3 December 2026 at the residence of the Ambassador of the Kingdom of the Netherlands in London.
- The Pneumococcal Vaccination Atlas. The Atlas covers Europe and the 21 APEC economies and has been developed with the support of MSD. Asia-Pacific data is as of August 2026. pneumoniaatlas.org/ap-atlas
- Media contact. press@ilcuk.org.uk| +44 (0) 203 752 5794
References
- International Longevity Centre UK (2026). The next frontier: Healthy ageing, prevention and economic growth in China. Supported by Pfizer. Includes ILC analysis of Global Burden of Disease data (productivity loss, 2022 data) and National Transfer Accounts data (consumption).
- International Longevity Centre UK (2026). Healthy Ageing and Prevention Index, latest wave. Full publication 3 December 2026.
- International Longevity Centre UK (2026). Pneumococcal vaccination in Asia-Pacific – the current situation. 21 August 2026. See also the Asia-Pacific Atlas.
- International Longevity Centre UK (2026). Making longevity work: equipping the UK to engage with China’s ageing economy. Commissioned by the British Embassy Beijing (FCDO).
- ILC analysis extending to China, based on Office of Health Economics (2024). The socio-economic value of adult immunisation programmes.
- ILC analysis of the WHO Global Health Expenditure Database.
- Caixin Global (2025). China to offer free HPV shots for girls starting next month; Xinhua (2025). China adds HPV vaccine to national immunization program.
- China Daily (2026). Long-term care insurance rolled out.
- Hong Kong Trade Development Council (2026). Chinese mainland silver economy opportunities.
- Department for Business and Trade (2026). China trade and investment factsheet.
- Institute for Health Metrics and Evaluation (2025). Global Burden of Disease Study 2023. Analysis for ILC’s Healthy Ageing and Prevention Index.
- General Administration of Customs of China, trade data for January–October 2026, as reported by AFP (Kuwait Times, 10 November 2026) and CNN (9 November 2026).
- Beijing Municipal Government (2026). Beijing records blue skies on 95.3% of days in 2025. 5 January; The Star (2026). Chinese capital Beijing declares major victory against air pollution. 4 January.
- China Daily (2017). Soccer granny wins UK trip. 31 March.
- China-Britain Business Council (2024). CBBC member survey 2024: why China matters. As cited in reference 4.
